Genelux Common Company Insiders
| GNLX Stock | 3.93 0.15 3.68% |
Genelux Common employs about 24 people. The company is managed by 8 executives with a total tenure of roughly 56 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive. Break down of Genelux Common's management performance can provide insight into the company performance.
Genelux |
Genelux Common Management Team Effectiveness
The company has return on total asset (ROA) of (0.4461) % which means that it has lost $0.4461 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8857) %, meaning that it created substantial loss on money invested by shareholders. Genelux Common's management efficiency ratios could be used to measure how well Genelux Common manages its routine affairs as well as how well it operates its assets and liabilities.Genelux Common Workforce Comparison
Genelux Common is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,478. Genelux Common claims roughly 24.0 in number of employees contributing just under 2% to equities under Health Care industry.
Genelux Common Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genelux Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genelux Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Genelux Common insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tyree James L over a month ago Disposition of 3460 shares by Tyree James L of Genelux Common at 2.46 subject to Rule 16b-3 | ||
Joseph Cappello over a month ago Disposition of 6300 shares by Joseph Cappello of Genelux Common at 2.34 subject to Rule 16b-3 | ||
Scigalla Paul over three months ago Acquisition by Scigalla Paul of 16666 shares of Genelux Common at 6.0 subject to Rule 16b-3 | ||
Thomas John over three months ago Acquisition by Thomas John of 2500 shares of Genelux Common at 5.25 subject to Rule 16b-3 | ||
Yong Yu over three months ago Disposition of 5200 shares by Yong Yu of Genelux Common at 19.106 subject to Rule 16b-3 | ||
Joseph Cappello over three months ago Acquisition by Joseph Cappello of 11557 shares of Genelux Common subject to Rule 16b-3 | ||
Szalay Aladar over three months ago Disposition of 33080 shares by Szalay Aladar of Genelux Common at 2.5679 subject to Rule 16b-3 | ||
Szalay Aladar over three months ago Disposition of 31777 shares by Szalay Aladar of Genelux Common at 2.7294 subject to Rule 16b-3 |
Genelux Common Notable Stakeholders
A Genelux Common stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genelux Common often face trade-offs trying to please all of them. Genelux Common's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genelux Common's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas JD | CEO Chairman | Profile | |
| Caroline Jewett | VP Quality | Profile | |
| Ralph BSc | Head Affairs | Profile | |
| Sean JD | General Secretary | Profile | |
| Lourie Zak | Chief Officer | Profile | |
| Joseph Cappello | Chief Officer | Profile | |
| Yong Yu | Senior Development | Profile | |
| Pr MD | Chief Officer | Profile |
About Genelux Common Management Performance
The success or failure of an entity such as Genelux Common often depends on how effective the management is. Genelux Common management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genelux management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genelux management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Genelux Common's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genelux Common. Check Genelux Common's Beneish M Score to see the likelihood of Genelux Common's management manipulating its earnings.
Genelux Common Workforce Analysis
Traditionally, organizations such as Genelux Common use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genelux Common within its industry.Genelux Common Manpower Efficiency
Return on Genelux Common Manpower
| Revenue Per Employee | 7.1K | |
| Revenue Per Executive | 21.2K | |
| Net Loss Per Employee | 1.2M | |
| Net Loss Per Executive | 3.5M | |
| Working Capital Per Employee | 735.4K | |
| Working Capital Per Executive | 2.2M |
Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.